Enterovirus 71 seroepidemiology in Taiwan in 2017 and comparison of those rates in 1997, 1999 and 2007

PLoS One. 2019 Oct 17;14(10):e0224110. doi: 10.1371/journal.pone.0224110. eCollection 2019.

Abstract

Background: During recent 20 years, enterovirus 71 (EV71) has emerged as a major concern among children, particularly in the Asia-Pacific region. To understand current EV71 serostatus, to find risk factors associated with EV71 infection and to establish future EV71 vaccine policy, we performed a seroepidemiology study in Taiwan in 2017.

Methods: After informed consent was obtained, we enrolled preschool children, 6-15-year-old students, 16-50-year-old people. They received a questionnaire and a blood sample was collected to measure the EV71 neutralization antibody.

Results: Altogether, 920 subjects were enrolled with a male-to-female ratio of 1.03. The EV71 seropositive rate was 10% (8/82) in infants, 4% (6/153) in 1-year-old children, 8% (7/83) in 2-year-old children, 8% (13/156) in 3-5-year-old children, 31% (38/122) in 6-11-year-old primary school students, 45% (54/121) in 12-15-year-old high school students and 75% (152/203) in 16-50-year-old people. Risk factors associated with EV71 seropositivity in preschool children were female gender, having siblings, more siblings, and contact with herpangina or hand-foot-and-mouth disease. The risk factor with EV71 seropositivity in 16-50-year-old people was having children in their families in addition to older age (p<0.001). Compared with the rates in 1997, 1999 and 2007, the rates in children were significantly lower in 2017.

Conclusion: EV71 seropositive rates were very low, at 4% to 10%, in preschool children and not high, at 31%, in primary school students. Preschool children are highly susceptible and need EV71 vaccine most.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Neutralizing / blood
  • Child
  • Child, Preschool
  • Enterovirus A, Human / immunology
  • Enterovirus A, Human / isolation & purification
  • Enterovirus Infections / complications
  • Enterovirus Infections / diagnosis*
  • Enterovirus Infections / epidemiology
  • Enterovirus Infections / virology
  • Female
  • Hand, Foot and Mouth Disease / complications
  • Hand, Foot and Mouth Disease / diagnosis
  • Herpangina / complications
  • Herpangina / diagnosis
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Risk Factors
  • Sex Factors
  • Taiwan / epidemiology
  • Young Adult

Substances

  • Antibodies, Neutralizing

Grants and funding

This study was supported by grants from the Taiwan Centers for Disease Control, the Ministry of Health and Welfare, Taiwan (grant number MOHW 106-CDC-C-114-000117 to L-YC) and the Ministry of Science and Technology, Taiwan (grant numbers MOST 105-2320-B-002-016 and 105-2314-B-002-139-MY3) to L-YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.